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THE COST OF TREATING CHRONIC NON-COMMUNICABLE DISEASES IN THE 
CARIBBEAN: DOES IT MATTER? 
 
Abstract 
 
Heart disease and Type 2 diabetes mellitus are among the two leading causes of death in the 
CARICOM member states with HIV/AIDS a distant sixth.  Attention is now being paid to non-
communicable diseases which have outpaced communicable diseases as the major cause of 
death.  This paper investigated the link between the public medical cost of treating chronic non-
communicable diseases, namely heart disease and diabetes, on national output in Barbados, 
Guyana, Jamaica, and Trinidad and Tobago.  The results provide evidence that the public 
medical cost of treating chronic non-communicable diseases does have a statistically significant 
negative impact on national output. 
 
Keywords: Economic Growth, Disease Burden, Human Development. 
JEL Classification: O11; I15; and I18 
 
 
Introduction  
The global pandemic of chronic non-communicable diseases (CNCDs) is palpable and 
presents a major public health challenge in the 21st century.   CNCDs include but are not limited 
to cardiovascular diseases, diabetes mellitus, and cancers.  Extensive clinical and statistical 
studies have identified several factors that increase the risk of CNCDs (Grundy et al., 2000; 
WHO, 2008b; Ng et al., 2006).  These factors can be grouped into four categories, namely, 
underlying socioeconomic, cultural, political and environmental determinants, such as 
globalization, urbanization, and aging population; modifiable risk factors, including unhealthy 
diet; physical inactivity; and tobacco use; non-modifiable risk factors, such as heredity and age; 
and intermediate risk factors of elevated blood pressure and glucose levels, abnormal blood 
lipids, overweight, and obesity (WHO, 2008b). CNCDs no doubt are harming the health of the 
global population, causing much preventable loss of life, loss of productivity, declines in quality 
of life, and billions of additional dollars spent each year on health care costs, as well as creating 
considerable burden for caregivers.    
According to the World Health Organization (WHO) (2009), the leading global risks for 
mortality in the world are hypertension (13%), tobacco use (9%), diabetes (6%), physical 
inactivity (6%), and overweight and obesity (5%), these global risks are also largely the 
contributing factors or causes of CNCDs.  In 2005, an estimated 35 million deaths occurred as a 
result of CNCDs, primarily cardiovascular diseases, diabetes, cancers, and chronic respiratory 
diseases.  Globally, this figure accounts for 60% of all deaths, with 80% of deaths in low- and 
middle-income countries due to CNCDs, and approximately 16 million deaths are individuals 
under the age 70 years (WHO 2008a; WHO 2008b; WHO, 2005; Daar et al., 2007).  
Additionally, it is estimated that deaths from CNCDs will increase by 17% between 2005 and 
2015 (WHO, 2008b). 
With substantial increases in the prevalence of these diseases and the associated costs for 
treatment, which in most developing countries is the undertaking of the government, and 
understanding that resources are scarce, we cannot help but ask: do these diseases affect the level 
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of national output?  In this paper, we attempt to answer this fundamental question by focusing on 
the Caribbean region, with the concentration on four countries, namely, Jamaica, Trinidad and 
Tobago, Guyana, and Barbados.  These countries were chosen because of the varying Human 
Development Index rankings, with Barbados being ranked as “Very High Human Development,” 
Jamaica and Trinidad and Tobago ranked as “High Human Development” and Guyana is ranked 
“Medium Human Development.”  This we believe captures countries at different stages of 
human development and will allow us to compare the ranking as it relates to economic growth 
which gives us unique insight.  In Jamaica, CNCDs have emerged as the leading causes of 
mortality and morbidity, accounting for the highest numbers of discharges (including death) 
from hospitals (Ministry of Health and Environment, 2007).  According to reports, chronic 
diseases comprise over 70% of all deaths in Jamaica (Williams, 2010).  Further, deaths from 
chronic conditions, such as cardiovascular diseases, neoplasms, chronic respiratory diseases, 
diabetes, and hypertension represent the leading threats to health and well-being in Jamaica 
(Williams, 2010).   
In Trinidad and Tobago like its other CARICOM members, heart disease is the leading 
cause of morbidity and mortality relative to CNCDs.  Diabetes and malignant neoplasms are still 
the major CNCDs, with the number of deaths attributed to diabetes remaining relatively constant 
during the 2004-2005 period (Ministry of Health, Trinidad and Tobago, 2005).  In the case of 
Barbados, the leading cause of mortality and morbidity in relation to CNCDs includes diseases 
of pulmonary circulation and other forms of heart disease, cerebrovascular disease, ischemic 
heart disease, and hypertension (Report of the Chief Medical Officer 2004-2006, 2006).  During 
the periods 2004-2006, CNCDs account for the top five causes of death in Barbadians.  Diabetes 
mellitus ranked number one as the underlying cause of death in 2004 and 2006 and was second 
only to diseases of pulmonary circulation and other forms of heart disease in 2005 for the top 10 
principal causes of death with rates per thousand population (Report of the Chief Medical Officer 
2004-2006, 2006).   
Guyana like other countries in the Americas is experiencing an increase in morbidity and 
mortality from CNCDs, including heart disease, diabetes, cancers, and hypertension leading to 
stroke and kidney failure (Ministry of Health, Guyana, 2008).  An analysis of the 2008 Statistical 
Bulletin revealed that for the period January to December, the number of deaths due to CNCDs 
was 3,705, comprising 74.1% of all deaths defined by cause, with females accounting for most of 
the death.  The number of deaths among males from CNCDs was 1,925 (68.6%); for females 
there were 1,780 (81.0%) (Statistical Bulletin, 2008). 
There are many channels though which diseases can have an impact on the economy.  
Diseases in general, particularly chronic non-communicable diseases deprive individuals of their 
health and productive potential.  The burden of chronic diseases may invariably challenge 
individual or household income and savings, and compete with investment activities.  From 
countries’ perspective, chronic non-communicable diseases reduce life expectancy and 
ultimately economic productivity, thus depleting the quality and quantity of countries’ labor 
force.  This may result into lower national output and consequently lower income.  In contrast, 
good health improves levels of human capital and ultimately has a positive impact on national 
output.   
The paper is structured as follows.  First, we present a review of the literature followed 
by the model and the theoretical underpinning.  The final section of this paper discusses the 
results and makes some concluding remarks.   Since the purpose of the study is to examine the 
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effect of CNCDs on economic growth, we are careful to avoid policy recommendations at this 
point.    
 
Literature Review 
 
The case of the impact of CNCDs on economic growth is not a new issue to observers; in 
fact, several researchers (Bloom, Canning, and Sevilla; 2004; Abegunde and Stanciole, 2006; 
Abegunde, Mathers, Adem, Ortegon and Strong, 2007; and Bakare and Sanmi, 2011) have taken 
a holistic view of this issue, but have only applied it to certain regions or continents, such as the 
Latin America and Caribbean region, Asia, and Africa.  These continents are usually at the heart 
of this issue because they are regarded as peripheral regions or continents.  The unanimous 
assertion concerning the concentration of these regions or continents to this issue is that the 
effect of these diseases can easily be measured given the weakened health care structures in these 
regions or continents.  Another reason is that there is a clear correlation between the prevalence 
of these diseases (as a result of their environments) and their overall economic output.   
Acemoglu, Robinsion, and Johnson (2003), applied a historical perspective to examine 
the effect of health conditions, diseases and life expectancy on economic development from a 
historical perspective using pre-colonial and colonial Europe as a reference point.  The authors 
began by posing a striking question as to whether the differences in health conditions and disease 
environments are a major cause of the huge gap in income per capita between rich and poor 
countries (Acemoglu, et al., 2003).  They addressed the question they raised by asserting that 
although health conditions, diseases, and life expectancy adversely affect economic 
development, they cannot be considered as the major predictor of economic development; rather 
based on their previous work, they cite institutional differences as having a major effect on 
economic development (the major reason for the huge gap in income per capita between rich and 
poor countries.   
Acemoglu et al. (2003) cite three reasons why countries with unhealthy populations are 
confined to the label of “poor.”  According to their analysis, the first reason is that “unhealthy 
people are less productive” (Acemoglu, et al., 2003).  The reasoning behind this is that unhealthy 
people would usually miss work which would directly cut into their productivity, and when this 
is viewed in a general aspect the overall effect is a country whose overall workforce productivity 
has dwindled and this would invariably lead to low output.  The second reason is that “poor 
health conditions reduce life expectancy, which may reduce human capital investments because 
agents have shorter horizons” (Acemoglu, et al., 2003).  The third reason is that poor health may 
directly reduce human capital investments (Acemoglu, et al., 2003).  The authors then go on to 
provide evidence that suggests that there is “a strong correlation between measures of general 
health status of the population and economic performance” (Acemoglu, et al., 2003).  While their 
study of the effect of health on economic development was done on an individual level, the issue 
is that it still does not make a strong case for health to be a first order determinant of economic 
development.  The author consequently explored the possibility of an improvement in life 
expectancy and its effect on economic growth; this also leads them to the same conclusion.  
Finally the authors take an historical approach by looking at this issue from the perspective of 
pre-colonial and colonial Europe.  In these sections, the authors look at how diseases that the 
Europeans spread around during their conquests affected the regions they targeted and they 
concluded that “the diseases that Europeans brought specifically, the difference between 
American and European disease environments played a first order role in allowing rapid and 
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through European domination” (Acemoglu, et al., 2003).  They also looked at the diseases such 
as malaria and yellow fever that the Europeans encountered while colonizing certain regions. 
They concluded that this made European colonists establish institutions that were aimed at 
creating colonies habitable for them in which this invariably had a first order effect on economic 
development.   
Another paper that sheds light on the impact of health on economic development is the 
work of Abegunde and Stanciole (2006), where they examine “the economic impact of chronic 
diseases at a national level.”  The authors start by looking at the linkages between diseases and 
the economy.  In this section of the paper, they reveal that there is a direct relationship between 
health and the economy of a country.  This means that if a country is disease free, then its 
economy would flourish as it would invariably possess a healthy workforce which would 
translate into higher productivity and Gross Domestic Product (GDP) and vice versa.  The 
authors also cite that there are two approaches which the economic impact of chronic diseases 
can be explored, and they are “the cost perspective, that is exploring the economic cost of failing 
to intervene; and the benefit perspective, that is exploring the accruable gains from timely 
interventions” (Abegunde & Stanciole, 2006).  The authors then go into the model in which they 
want to use to support their thesis and estimate the impact of chronic diseases on the economic 
growth.  In this paper, the researchers use the Solow model which “combines the Cobb-Douglas 
function with the capital accumulation function to estimate the long run impact of chronic 
diseases on economic growth” (Abegunde & Stanciole, 2006).  The authors utilized GDP and 
medical cost data of 9 countries (Brazil, Canada, China, India, Nigeria, Pakistan, Russia, United 
Kingdom, and United Republic of Tanzania) over a specified period of time (i.e., 2005-2015) 
from the World Bank, WHO, and EIP.  The results of the author’s calibrations and estimations 
reveal that there would be a substantial loss in national income which is as a result of the 
consequences of chronic diseases.  Results also show that over time this loss in national income 
would more than double significantly if something is not done to combat this issue of chronic 
diseases.  The author’s results also indicate that “the burden of chronic disease poses appreciably 
greater constraints to economic performance in low and middle income countries” (Abegunde & 
Stanciole, 2006).  To support this assertion, results show that loss of national income in countries 
like China, India, and Pakistan are greater than those in countries like Canada and the United 
Kingdom.   
The work of Weil (2010) is another example of the effect health has on economic 
development.  This paper focuses specifically on the economic effects of diseases using a more 
quantitative approach in the African continent.  The author begins by shifting from the 
conventional medium through which the economic effect of diseases is measured, which is 
through its effect on GDP and instead explores its effect through utility. This then leads the 
author to assert that “changes in health in developing countries have effects on utility that are 
quite significant” (Weil, 2010).  According to the author, there are three channels in which 
diseases affect economic development; one is the proximate effect which is the direct effect one 
feels in relation to productivity.  For instance it is how one’s productivity is affected as a result 
of being sick.  This proximate effect can also be viewed from the standpoint of its effect on 
human capital accumulation.  The second one is through the size, growth rate, and age structure 
of the population.  Here one looks at how the diseases affect a certain demographic of the 
population and its size.  For instance, how a disease which affects only infants could give insight 
into how the whole economy could be affected as a whole.  The third one is the indirect channel 
through which diseases affect labor supply.  Next, the author uses the examination of regression 
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results from Gallup and Sachs as a guide to support his claim.  The author then compares the 
results of two works to determine the effect of diseases on life expectancy and invariably its 
effect on the economic outcome of the country.  The author also explores the use of instrumental 
variables to deal with the shortcomings of previous works.  He also looks at the possibility of 
aggregating the effect of diseases on economic outcome through individual channels.  This 
strategy, however, suffers the same problem similar to that discussed by Acemoglu, et al. (2003).  
The author also conducts a simulation which draws the conclusion that “while disease 
eradication or health improvements in general do have positive economic consequences, they are 
relatively small and long in coming” (Weil, 2010).  The author concluded his work by stating 
research priorities and lessons for policy makers.  He also concludes that if health improvements 
are coupled with positives phenomena that affect population such as access to education on 
family planning and openness to foreign direct policy, then its effect on economic development 
or outcomes could be substantial.    
The issue of health and its effect on economic development is one that has been of great 
concern to a lot of researchers, as evidenced from the literature.  While the economic impact of 
CNCDs, NDCs, and infectious diseases have been studied for the various regions in the world by 
international organizations, such as WHO and independent researchers, little is known about the 
relevance of the findings of those studies and little attention is paid to country specific analysis 
especially those in the Caribbean, and this thus lays the foundation of our research.   
The Macroeconomic Effect of Chronic Noncommunicable Diseases 
 The macroeconomic cost of CNCDs to a country can be estimated using the accounting 
or cost of illness method in which the monetary cost of illnesses, the value of lost productivity, 
and death are all summed up; economic growth models, which are used to assess the causal 
relationship between key input factors and output; and the full income method, which attempts to 
measure the societal welfare loss associated with ill health in money terms added to the loss of 
GDP (Abegunde, Mathers, Adam, Ortegon, & Strong, 2007).  While these three approaches have 
been used with great sophistication, the empirical results have neither been unanimous nor 
conclusive.   
In the case of the value of loss of productivity, there is an enormous financial impact of 
CNCDs on the economy.  Researchers have shown that indirect factors, such as absenteeism, 
disability, and job impairment can be two to three times that of direct health costs (Edington & 
Burton, 2003; Loeppke et al., 2003).  Additionally, CNCDs, such as heart disease and diabetes 
and/or associated risk factors such as obesity, tobacco use, and physical inactivity are clearly 
linked with higher direct health costs, greater job impairment (e.g., presenteeism), higher rates of 
disability, more sick days and absenteeism, higher workers’ compensation claims, and increase 
injury rate (Edington & Burton, 2003; Davis et al., 2005).   
The cost of illness approach produces misleading results at best.  The results using the 
cost of illness approach measures the non-medical costs, commonly called the indirect costs or 
the loss of production associated with disease.  Those costs are simplistically assumed to be the 
total time lost through death and illness multiplied by the wage rates and some accounting 
measure for unemployment.  This crude measure results in overestimation of lost income.  The 
full-income approach assigns a monetary value to welfare loss which is generally assumed to fall 
within the range of 100 and 200 times the level of per capita GDP.  These results in overall 
economic losses are very high and not necessarily reflective of the actual losses.  The growth 
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method, while straightforward yields the lowest effects.  In this paper, we utilize the growth 
effect which will establish the link.    
 Baldacci (2004) explored the role of health expenditures in economic growth using panel 
data for one hundred and twenty developing countries and found that for the period 1975-2000 
health expenditure had no effect on economic growth.  For his results, Baldacci inferred that 
health was a flow variable and not a stock variable.   Bloom et al., (2004) estimated a production 
function of aggregate economic growth as a function of capital stock, labor, and human capital.   
Their results, while it showed a positive link, did not consider how health is created.  
Figure 1.1 shows the channels through which health could contribute to an economy and 
ultimately economic growth.   Four channels are shown, though other may exist: enhanced labor 
productivity, higher labor supply, higher skills from better education and training, and savings 
available for investment in intellectual capital.  Our analysis proceeds on the basis of these 
interactions. 
 
Figure 1.1: From Health to Wealth (and Back) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Modified from Bloom, Canning, and Jamison, 2004 
 
    The relative lack of convincing, unanimous and conclusive economic arguments for 
investing in policies that will combat CNCDs may also help to explain why the conditions have 
not been placed on the high priority of initiatives to be funded. 
 
  
Methodology of the Study 
 
 This section addresses the issues that relate to the methodology of the study and specifies 
the model.    
 
The Data and Methods 
 Data were obtained from the World Bank, the United Nations Global Disease Burden 
Reports, and from the United Nations’ Human Development Reports to estimate the effect of 
health care expenditure on CNCDs on economic growth.  The variables include Gross Domestic 
Product (GDP) and the public medical cost of treating CNCDs, which were obtained from the 
national health accounts of the WHO, and capital per worker.  Since the primary provider of 
Labor Productivity 
Labor Supply ECONOMY HEALTH 
Education 
Savings and Investment 
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health care is the government in the select countries, we assume that (x%) of the cost would be 
met through personal savings by the individuals and the remaining cost (y%) is borne by the 
government.  This was assumed to be 10% and 90% respectively.  Time series data were used in 
the study and are entirely secondary data covering the period 1990–2009.  We utilized ordinary 
least squares multiple regression analysis the generate result for the secondary data. 
   
The Hypothesis 
 This study verifies the null and the alternative hypothesis stated below: 
Ho: There is no significant relationship between the public medical cost of treating chronic non 
communicable diseases and economic growth in the sample countries. 
Ha: There is a significant relationship between the public medical cost of treating chronic non-
communicable diseases and economic growth in the sample countries. 
 
The Model 
 The model in this study adopts the approach used by Bakare and Sanmi (2011) derived 
from the Solow production function but with slight modification.  According to the Solow 
growth model and as highlighted in Bakare and Sanmi (2011) study, economic growth is the 
function of capital accumulation, and expansion of the labor force, and “exogenous” factor, 
technological progress which makes physical capital more productive.  The production function 
is specified as follows: 
     tttt LAKY ,,=         (1)                          
Where Y is real output, K is capital stock, A is technology, t is time dimension, and L is labor.
 Following Odusola (2002) and Bakare and Sanmi (2011), the model can be modified by 
adding human capital (H) such that:   
     )(,, ttttt LAHKY
βα=    (2) 
 
From equation (2) the linear form is expressed as:         
    
 )log(loglog 210 ttttt LALog ααα +Η+Κ=Υ    (3) 
Where =Κ t
 
capital stock and =Η t  human capital   
 
For estimation purposes, we restated equation (3) as: 
 LCPWLHCELGCFLGDP 3210 αααα +++=    (4) 
 
Where 
Log tΥ  = log of real output proxied as log of Gross Domestic Product (LGDP) 
Log tΚ  = log of capital stock proxied as log of Gross Capital Formation (LGCF) 
Log tΗ  = log of human capital proxied as log of public medical costs of treating CNCDs 
(LHCE)  
Log tL  = log of capital per worker proxied as log of Capital per Worker (LCPW) 
The a priori expectations are: 
,00 >α
 
,01 >α
 
,02 <α
 
03 >α  
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Equation (5) is the equation estimated in this study. 
 
The Theoretical Proposition of the Model 
 
 This model makes use of three variables (public medical costs of treating non-
communicable diseases, capital formation, and capital per worker) that have an impact on GDP.  
The coefficients explain the relationship each variable has with GDP and ultimately its impact on 
economic growth.  The original GDP equation was re-written to examine the effect of the cost of 
treating CNCDs on economic growth.  Public medical costs of treating CNCDs is expected to 
have a negative sign since an increase in CNCDs and consequently public spending on such 
diseases will have a negative impact on GDP.  While it is difficult to trace effect of CNCDs on 
profitability, we the sign of the coefficient(s) provide useful insight regarding the sources that 
can impede economic growth and development.  It is shown that CNCDs have a negative effect 
on labor productivity and consequently a negative impact on GDP.   The other variables are 
expected to have a positive sign. 
 At this point, it is important to emphasize that spending on health care, particularly to 
treat CNCDs is not ‘bad’ spending per se.  Figure 1.2 helps us to understand what this means.   
In Figure 1.2, the government has to allocate resources between the provision of health care (H) 
on the Y-axis and all other services (S) on the X-axis.  Let the total amount of services available 
to the society be denoted by s*.  The curve AB describes how health expenditure on health care 
services affects the provision of other services much needed by the society.  To understand how 
this works, if the amount of spending on health care is zero, then the government can provide B 
level of services to the society.  However, if spending on health care is at A, then the government 
cannot provide any other services. This implies, rooted in production possibility theory, that 
there is some optimum level of government spending on health care and all other services.   
Presumably, for illustrative purposes, we can choose an intermediate level such that h* and s* is 
the amount of health services and other services provided by the government.  The expenditure 
on health care is now given by the segment s*B.  This serves to highlight the effect of additional 
spending on CNCDs in the health arena, which means resources will have to be diverted from 
other uses or competing uses.  In this context, we expect that spending on CNCDs can have a 
negative impact on economic growth. 
 Our analysis does not consider other factors that might also influence national input.   
Specifically, it underplays the demand-side factors, such as the fact that increased health 
spending may lead to raising incomes through the multiplier.  The reason for doing so is the 
reliance on the empirical counterpart of the neoclassical Solow growth model of economic 
growth that assumed full employment via flexible prices.  Bringing in health expenditure as a 
demand factor in this model will essentially result in health spending influencing prices and the 
composition of national output.  This possibility is probably best modeled in terms of 
computable general equilibrium (GCE) models that have their own specification problems.  In 
the presence of a demand-side effect, the method of calculating aggregate economic impacts in 
this study will probably result in an overestimate of the true effect of CNCDs on national output. 
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Figure 1.2: The Health Trade Off 
 
Results and Analysis 
 
 Econometric estimation determines the country specific link between government 
spending on CNCDs and output.   The results are presented in Table 1. 
 The values of the adjusted r-squared for the model range from 74% to 86% and implies 
that the variations in GDP for the period under consideration is explained by the independent 
variables and the remaining variation is explained by variables not considered in the model.  
These adjusted r-squared values show the goodness of fit of the regression model.  The standard 
errors are less than half of the value of the coefficients which means the variables in 
consideration are statistically significant.   
Drawing from the theoretical propositions, a negative coefficient for LHCE means that 
CNCDs have a negative impact on GDP.  The Durbin-Watson values all fall within the 
determinate region and this indicates that there is no problem of auto correlation among the 
explanatory variables.    
Emphasis is placed on the negative coefficient for health care expenditure in Barbados, 
Jamaica and Trinidad and Tobago.  This means that expenditure on CNCDs, as measured, has a 
negative impact on the economy.  However, in Guyana, the variable carries a positive sign which 
points to some differences on the effect.  Taking a closer look at the data sets for Guyana, we 
observed that 74.1% of all deaths are due to CNCDs and females account for most of the deaths.  
In Guyana, the unemployment rate among females is the highest which means that women are 
largely underrepresented in the workplace.  What we propose here as a plausible explanation is 
that since most of the CNCD deaths are female and since women are not largely part of the 
workforce, then their falling productivity levels, due to CNCDs are not sufficiently high enough 
to have a negative impact on economic growth of course research on other dependent variables 
would have to be conducted to confirm this conclusion. 
H 
S 
E 
h* 
s* 
Health 
Expenditure
A 
B 
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Table 1: Regression Results and Analysis 
Variable Barbados Guyana Trinidad & Tobago Jamaica 
LHCE 
 
-0.0055* 
 
 
0.0012** 
 
 
-0.0005* 
 
 
-0.0003* 
 
LGCF 
 
0.0059** 
 
 
0.0025*** 
 
 
-0.0014** 
 
 
-0.0003** 
 
LCPW 
 
0.0031** 
 
 
0.0003 
 
 
1.1432** 
 
 
0.1435** 
 
2R  0.86 
 
0.75 
 
 
0.74 
 
 
0.79 
 
Durbin Watson 
Statistic 1.983345 1.976544 1.998765 2.000541 
*p < .1, ** P< .05, ***P< .01 
  
 In summary, the econometric results satisfy all tests of validity and show a statistically 
relationships between the dependent and independent variables ceteris paribus.  Thus, we accept 
the alternative hypothesis that states: there is a significant relationship between public medical 
cost of treating CNCDs and economic growth in the sample countries.    
 
Conclusions 
 
 This paper investigated the link between public medical costs of treating CNCDs on 
economic growth in Barbados, Guyana, Jamaica, and Trinidad and Tobago for the period 1990–
2009.  In Barbados, Trinidad and Tobago and Jamaica, the public medical costs of treating 
CNCDs have a negative effect on output while in Guyana it has a positive impact.  It can be 
concluded that public expenditure on health care, particularly CNCDs has a vital role to play in 
economic development in the Caribbean and governments should focus on addressing any 
shortcomings within the health care system to ensure provision of effective and efficient health 
care, as well as allocating resources for preventive health care since most CNCDs are 
preventable or at least the effects of which can be mitigated with proper dietary choices and 
regular exercise.  Provision of adequate health care normally improves the health, life 
expectancy, and the productivity of labor which will have positive effects on economic growth, 
as well as overall quality of life.  
 
Policy Implications 
 
These conclusions present some clear implications for policies needed to address 
CNCDs. These policies should to be comprehensive in order to address needs from farm to fork 
and to promote healthy lifestyles for any given population. The determinants of CNCDs are 
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complex, numerous, and operate at the social, economic, environmental, and individual levels. 
CNCDs inflict a significant economic burden on the entire population of a country, i.e., CNCDs 
have tremendous impact not only on patients, but also on households, communities, employers, 
and health care systems, as well as government budgets.  Currently, many CNCD interventions 
are not widely available in low- and middle-income countries. Hence, long term sustainability of 
financing mechanisms that governments of Barbados, Guyana, Jamaica, and Trinidad and 
Tobago have established requires the diffusion of more primary effective prevention methods.  
These methods should be specifically designed to stem the early onset of CNCDs, thereby 
limiting their effects on life expectancy, productivity of labor, and quality of life, and supporting 
economic growth. Additionally, public health approaches that affect large numbers of different 
populations, especially children and adolescents are needed.   
Given that poor dietary habits, physical inactivity and tobacco and alcohol consumption 
are the four (4) primary denominators in most CNCDs, governments should also implement 
primary preventative methods targeting these areas. Thus far, legislation prohibiting smoking in 
public places and spaces as a means to alleviate some of the economics burden of health care 
associated with unhealthy lifestyles has been established in the aforementioned countries.  
However, more work needs to be done.  Unhealthy dietary habits could be targeted by means of 
higher taxes on fast foods, i.e., less nutritional dense food and implementing legislation on trans 
fat in foods.  Governments can offer incentives at the community level to encourage physical 
activity, such as no taxes on gyms.  In terms of alcohol, legislation should be established to 
increase the age of access to alcohol. 
In addition to addressing the four (4) major causes of CNCDs, governments must 
evaluate the health care system in terms of providing a more efficient and equitable system.  We 
have stated that CNCDs is a crucial public health challenge, therefore in an effort to help control 
this problem, governments must examine the services offered by the health care sector and 
consider, putting policies in place that will improve the quality of care, efficiency, and access of 
the healthcare system.   
Finally, health sector policymakers should seek to collect data that would establish the 
following relationships: (1) as health increases then the cost of medical care decreases and (2) as 
health increases then the level of productivity increases.  This will define a sound basis for what 
may appear to be harsh policy measures relating to the four major determinants of CNCDs. 
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